Screener
Incyte INCY Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Incyte in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Incyte’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000879169-26-000056
| Line item | June 30,2026 | December 31,2025* |
|---|---|---|
| Total liabilities | 1,528,220 | 1,790,495 |
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: | ||
| Preferred Stock, $0.001 par value; 5,000,000 shares authorized; none issued or outstanding | — | — |
| Common Stock, $0.001 par value; 400,000,000 shares authorized; 200,977,687 and 198,460,009 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 201 | 198 |
| Additional paid-in capital | 5,221,804 | 4,928,049 |
| Accumulated other comprehensive income | 19,718 | 25,462 |
| Retained earnings | 1,102,704 | 213,769 |
Item 1. Financial Statements
FAQ
- What is Incyte's preferred stock, shares authorized?
- Incyte (INCY) reported preferred stock, shares authorized of $5M in Q2 2026.
- How has Incyte's preferred stock, shares authorized changed year-over-year?
- Incyte's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for Incyte's preferred stock, shares authorized?
- Over 4 years (2021 to 2025), Incyte's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.
Ask your AI about Incyte's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude